Janssen Biotech Loses Patent For Lab-Grown Cells
Janssen Biotech has lost its case at a European Patent Office appellate board to patent its method for treating Type 1 diabetes through lab-grown cells, after the patent appeals board agreed...To view the full article, register now.
Already a subscriber? Click here to view full article